Impact of Integrated Nursing and Digital Droplet PCR on Bullous Dermatoid Conditions: A Randomized Controlled Trial

Bullous skin disease is an autoimmune disease characterized by the formation of blisters on the skin or mucous membrane, which seriously impairs the quality of life and overall health. Similar to the research on biomolecules (mechanics of protein interaction), cells (including cell membrane elasticity, cell adhesion, cytoskeletal dynamics, response to mechanical stimulation, cell deformation and cell endoforce transfer) and tissue levels, this study aims to use advanced diagnostic tools - digital droplet PCR (ddPCR) - combined with comprehensive nursing interventions, such as health education, emotional support and tailor-made health plans, to enhance disease monitoring and understanding. The purpose is to improve the nursing method and improve the treatment effect through accurate disease assessment. A 12-week randomized controlled trial involved 60 patients with bullous skin disease. The results showed that the overall response rate of the experimental group (who received ddPCR comprehensive care) was 92%, which was significantly higher than the 76% of the control group that only received standard treatment. The experimental group also showed a significant reduction in the area of skin damage and the intensity of itching. Digital droplet PCR shows high sensitivity and specificity in detecting genetic mutations associated with bullous skin disease, thus supporting personalized treatment. By using ddPCR to continuously track disease activity markers, which may be related to molecular mechanics and biomolecular force spectrum (which may be the basis of the molecular mechanism of the disease), treatment strategies can be fine-tuned, including drug dosage and wound care programs, to accelerate recovery.